Tirzepatide is a dual GIP/GLP-1 receptor agonist, given as a once-weekly subcutaneous injection. It is an FDA-approved prescription medicine: the FDA has approved tirzepatide as Mounjaro (for type 2 diabetes) and as Zepbound (for chronic weight management), both made by Eli Lilly. This calculator is an educational maths tool, not medical advice. It turns your vial strength, BAC water volume and target dose into a precise draw on a U-100 insulin syringe, so you can check the maths yourself and talk through any dose with your clinician or pharmacy. All dosing information on this page is reference information from the FDA-approved label, and compounded or research vials are not the approved products.
The worked example used throughout this page is a 10 mg vial mixed with 2 mL of bacteriostatic water. That gives a concentration of 5 mg/mL — 5,000 mcg/mL — so a 2.5 mg dose is 0.5 mL, which is 50 units on a U-100 insulin syringe, and one vial gives 4 doses of 2.5 mg. A 1 mL syringe holds 100 units, so those 50 units sit at the 50-unit mark on the barrel — the halfway mark. From the same mix, a 5 mg dose is 1.0 mL (100 units), a 7.5 mg dose is 1.5 mL (150 units) and a 10 mg dose is 2.0 mL (200 units). The same maths works for any vial strength, from 10 mg to larger vials of 20 mg, 30 mg, 40 mg, 50 mg and 60 mg: divide the vial strength by the water volume to get the concentration, then divide your target dose by the concentration to get the volume to draw.
Tirzepatide acts on two receptors, GIP and GLP-1 — the same two signals that help control blood sugar and appetite. Because it is FDA-approved, its dosing is set out in the official prescribing information (the FDA label): treatment starts at 2.5 mg once weekly, then increases by 2.5 mg every 4 weeks as tolerated, up to a maximum of 15 mg once weekly. The approved products, Mounjaro and Zepbound, are supplied in single-dose pens; the vial-and-syringe maths on this page is an educational reference for people who want to understand how the same doses are calculated. This page reflects the information available as of 8 November 2026.
Tirzepatide Reconstitution Calculator
Enter your vial size, bacteriostatic water, and target dose to get an exact syringe draw – with a live visual and a round-unit optimizer so you never eyeball an odd tick mark again.
Same three formulas as the homepage calculator: concentration = vial strength divided by BAC water; draw volume = dose divided by concentration; units = draw volume × 100 on a U-100 syringe.
Quick Answers: Tirzepatide Doses in Units
These are the quick answers for the most common example on this page — a 10 mg vial of tirzepatide mixed with 2 mL of bacteriostatic water, which gives a concentration of 5 mg/mL. Read them off a U-100 insulin syringe, where a 1 mL syringe holds 100 units. This is educational maths, not a dose recommendation: the doses below are the FDA label titration steps for tirzepatide, and you should follow the label and your clinician or pharmacy instructions.
| Target dose | Draw volume | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.5 mL | 50 units |
| 5 mg | 1.0 mL | 100 units |
| 7.5 mg | 1.5 mL | 150 units |
| 10 mg | 2.0 mL | 200 units |
| 12.5 mg | 2.5 mL | 250 units |
| 15 mg | 3.0 mL | 300 units |
The 2.5 mg and 5 mg draws fit in a single 1 mL syringe. The 7.5 mg draw (1.5 mL, 150 units), the 10 mg draw (2.0 mL, 200 units), the 12.5 mg draw (2.5 mL, 250 units) and the 15 mg draw (3.0 mL, 300 units) do not — they are more than one full 1 mL syringe, so they would need a larger syringe or more than one injection. If your vial or water volume is different, run your own numbers through the calculator above: the units change with the concentration, so always calculate from your own vial and water volume.
Quick Math Example
Take the 10 mg vial with 2 mL of BAC water as the first example, and the 20 mg vial with the same 2 mL as the second. The concentration of the 10 mg vial is 10 ÷ 2 = 5 mg/mL (5,000 mcg/mL), and a 2.5 mg dose needs 2.5 ÷ 5 = 0.5 mL, which is 50 units on a U-100 syringe. One 10 mg vial therefore gives 4 doses of 2.5 mg. The 20 mg vial is twice as strong: 20 ÷ 2 = 10 mg/mL (10,000 mcg/mL), so a 5 mg dose needs 5 ÷ 10 = 0.5 mL — also 50 units — and one 20 mg vial gives 4 doses of 5 mg. A 1 mL draw from the 5 mg/mL mix is 5 mg, or 100 units. Whenever you change the vial strength or the water volume, re-run the calculator above: the concentration changes, and so does the draw.
How the Tirzepatide Calculation / Math Works
Step 1 — Find the concentration. Divide the vial strength by the bacteriostatic water volume. A 10 mg vial with 2 mL of water is 10 ÷ 2 = 5 mg/mL — that is 5,000 mcg/mL (multiply mg by 1,000 to get mcg: 10 mg is 10,000 mcg), or 50 mcg per unit on a U-100 syringe — because each unit is 0.01 mL, so 5 mg/mL × 0.01 mL = 0.05 mg, or 50 mcg.
Step 2 — Find the draw volume. Divide the target dose by the concentration to get an exact volume. For a 2.5 mg dose (2,500 mcg) from a 5 mg/mL mix: 2.5 ÷ 5 = 0.5 mL, which is 50 units. A 10 mg vial at a 2.5 mg dose gives 4 doses. For a 5 mg dose from the same mix: 5 ÷ 5 = 1.0 mL, or 100 units.
Step 3 — Turn the volume into units. On a U-100 insulin syringe, 1 mL is 100 units, so multiply the draw volume in mL by 100. A 0.5 mL draw is 50 units; a 1.0 mL draw is 100 units; a 1.5 mL draw is 150 units and a 2.0 mL draw is 200 units. The unit markings are in hundredths of a millilitre: 0.01 mL is 1 unit. Small draws are easier to read on a 0.5 mL (50 unit) syringe.
Dosage Formula
Three formulas do all the work. Use them in this order, and keep the units straight (mg for the dose, mL for water and volume, mcg only when you need to compare labels).
- Concentration (mg/mL) = vial mg ÷ BAC water mL. Example: 10 mg ÷ 2 mL = 5 mg/mL.
- Draw volume (mL) = dose mg ÷ concentration (mg/mL). Example: 2.5 mg ÷ 5 mg/mL = 0.5 mL.
- U-100 units = draw volume (mL) × 100. Example: 0.5 mL × 100 = 50 U-100 units.
On a U-100 insulin syringe the scale is simple: 1 mL is 100 units, so each unit is 0.01 mL. The formula stays the same whatever the vial size: a bigger vial only changes the concentration, and a bigger water volume only dilutes it. If you know the vial size in mg and the dose in mg, the calculator above applies these three formulas for you.
Tirzepatide 10 mg Vial with 2 mL Example
This is the reference example for the whole page. Start with the tirzepatide vial: a 10 mg vial + 2 mL of BAC water, taking the starting dose of 2.5 mg.
- Concentration: 10 ÷ 2 = 5 mg/mL (5,000 mcg/mL). Written out: 10 mg / 2 mL = 5 mg/mL.
- Draw volume: the target dose is 2.5 mg (2,500 mcg), so 2.5 ÷ 5 = 0.5 mL.
- Units: 0.5 × 100 = 50 U-100 units. Draw 50 units on a U-100 syringe.
So: 10 mg in 2 mL gives 5 mg/mL, and 2.5 mg from that mix is 0.5 mL — 50 units. One vial gives four 2.5 mg doses.
Tirzepatide 20 mg Vial with 2 mL Example
Take a 5 mg dose — the second step on the label — from a stronger vial: a 20 mg tirzepatide vial with 2 mL of water.
- Concentration: 20 mg / 2 mL = 10 mg/mL (10,000 mcg/mL) — double the concentration of the 10 mg vial.
- Draw volume: 5,000 mcg / 10,000 mcg per mL = 0.5 mL.
- Units: 0.5 mL × 100 = 50 U-100 units.
The dose is twice the starting dose, but the mix is twice as strong, so the draw stays the same: 5 mg is 50 units from a 20 mg vial in 2 mL of water — and one vial gives four 5 mg doses.
30 mg Vial + 3 mL BAC Water, 5 mg Dose
Now mix a larger vial with more water — 30 mg of tirzepatide in 3 mL of BAC water — and take the same 5 mg target dose.
- Concentration: 30 ÷ 3 = 10 mg/mL (10,000 mcg/mL).
- Draw volume: 5 ÷ 10 = 0.5 mL.
- Units: 0.5 × 100 = 50 units on a U-100 syringe.
From this mix, 2.5 mg is 0.25 mL — 25 units. A 30 mg vial gives six 5 mg doses; adding more BAC water dilutes the mix, so more water means a larger draw for the same dose.
Example Tirzepatide Dosage Table
Always verify your vial label before you draw — this table is for education, and the same dose can be a very different number of units depending on the mix.
| Vial | BAC water | Concentration | Dose | Draw | Units (U-100) |
|---|---|---|---|---|---|
| 10 mg | 2 mL | 5 mg/mL | 2.5 mg | 0.5 mL | 50 units |
| 10 mg | 2 mL | 5 mg/mL | 5 mg | 1.0 mL | 100 units |
| 20 mg | 2 mL | 10 mg/mL | 5 mg | 0.5 mL | 50 units |
| 30 mg | 3 mL | 10 mg/mL | 5 mg | 0.5 mL | 50 units |
Worked from the concentration each time: dose ÷ concentration = draw; draw × 100 = U-100 units. Check the row against your own vial and water volume before you use it.
Choosing BAC Water for a Tirzepatide Titration
There is no single right amount of BAC water: the reconstitution volume sets the strength of the mix, and the right choice depends on the amount of tirzepatide in the vial and how small your doses are. For a titration that steps up over several weeks, a lower concentration gives clearer, more readable unit marks at the early titration steps, when doses are smallest — but every time you step up, the draw grows, so re-run the math for the new dose.
| BAC water (10 mg vial) | Concentration | Draw for a 2.5 mg dose | Units per dose |
|---|---|---|---|
| 1 mL | 10 mg/mL | 0.25 mL | 25 units |
| 2 mL | 5 mg/mL | 0.5 mL | 50 units |
| 3 mL | 3.33 mg/mL | 0.75 mL | 75 units |
2 mL is the practical middle ground for titration: from this mix the label doses are easy to read — 2.5 mg is 0.5 mL (50 units), 5 mg is 1.0 mL (100 units), 7.5 mg is 1.5 mL (150 units) and 10 mg is 2.0 mL (200 units). Less water gives smaller, harder-to-read draws; more water makes the maintenance doses too large for a 1 mL syringe.
Tirzepatide Dosage Calculator in Units — Dose to U-100 Units Chart
The chart below uses the default water volume on this page: 2 mL of BAC water in a 10 mg vial of tirzepatide (5 mg/mL). It lists every dose on the FDA label.
| Dose | Draw volume | Units (U-100) |
|---|---|---|
| 2.5 mg | 0.5 mL | 50 units |
| 5 mg | 1.0 mL | 100 units |
| 7.5 mg | 1.5 mL | 150 units |
| 10 mg | 2.0 mL | 200 units |
| 12.5 mg | 2.5 mL | 250 units |
| 15 mg | 3.0 mL | 300 units |
Draws above 100 units do not fit a standard 1 mL U-100 insulin syringe (100 units = 1 mL), so for the 7.5 mg dose and above you need a larger syringe or a split dose. The 2.5 mg and 5 mg draws both fit in a single 1 mL syringe. The label increases the dose by 2.5 mg every 4 weeks, up to a maximum of 15 mg.
Tirzepatide Reconstitution Reference — Units per Dose by Vial Size (2 mL BAC Water)
Use 2 mL BAC water throughout this reference. It is reference maths, not a dose recommendation — follow your clinician or pharmacy instructions. The draws use a standard 1 mL U-100 insulin syringe (100 units).
| Vial | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 10 mg | 5 mg/mL | 0.5 mL / 50 u | 1.0 mL / 100 u | 1.5 mL / 150 u | 2.0 mL / 200 u | 3.0 mL / 300 u |
| 20 mg | 10 mg/mL | 0.25 mL / 25 u | 0.5 mL / 50 u | 0.75 mL / 75 u | 1.0 mL / 100 u | 1.5 mL / 150 u |
| 30 mg | 15 mg/mL | 0.17 mL / 16.7 u | 0.33 mL / 33.3 u | 0.5 mL / 50 u | 0.67 mL / 66.7 u | 1.0 mL / 100 u |
| 40 mg | 20 mg/mL | 0.125 mL / 12.5 u | 0.25 mL / 25 u | 0.375 mL / 37.5 u | 0.5 mL / 50 u | 0.75 mL / 75 u |
| 50 mg | 25 mg/mL | 0.1 mL / 10 u | 0.2 mL / 20 u | 0.3 mL / 30 u | 0.4 mL / 40 u | 0.6 mL / 60 u |
| 60 mg | 30 mg/mL | 0.08 mL / 8.3 u | 0.17 mL / 16.7 u | 0.25 mL / 25 u | 0.33 mL / 33.3 u | 0.5 mL / 50 u |
Draws over 1 mL do not fit a standard 1 mL U-100 insulin syringe. A larger vial at the same 2 mL of water is a stronger mix, so the same dose needs a smaller draw — that is why the 60 mg row reads so much lower than the 10 mg row.
Syringe
Always check the syringe label before you draw. A U-100 insulin syringe is the standard scale: 1 mL is 100 units, so each unit is 0.01 mL. From the standard mix on this page — a 10 mg vial in 2 mL of BAC water (5 mg/mL) — a 2.5 mg dose is 0.5 mL, or 50 units, which sits halfway up a 1 mL syringe, and a 5 mg dose is 1.0 mL, or 100 units, which fills it. Draws above 5 mg from this mix need a larger syringe or a split dose. A 0.5 mL (50-unit) syringe is useful for the smallest draws, and a 29–31 gauge needle is typical for this injection.
Tirzepatide Reconstitution by Vial Size
Tirzepatide is an FDA-approved prescription medicine, and the doses below are the label titration doses (2.5 mg, 5 mg, 7.5 mg, 10 mg and 15 mg), once weekly. The tables give the weekly dose in millilitres and U-100 units for each vial size, with 1 mL, 2 mL and 3 mL of BAC water. Every water volume below fits a standard 3 mL vial, but check your vial’s fill capacity before you add water, and always follow the label and your prescriber’s instructions.
10 mg Vial
The 10 mg vial covers the early titration steps in a single reconstitution. At 5 mg/mL (2 mL of water), a 2.5 mg dose is 0.5 mL (50 units) and a 5 mg dose is 1.0 mL (100 units).
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 10 mg/mL | 0.25 mL (25 u) | 0.5 mL (50 u) | 0.75 mL (75 u) | 1.0 mL (100 u) | 1.5 mL (150 u) |
| 2 mL | 5 mg/mL | 0.5 mL (50 u) | 1.0 mL (100 u) | 1.5 mL (150 u) | 2.0 mL (200 u) | 3.0 mL (300 u) |
| 3 mL | 3.33 mg/mL | 0.75 mL (75 u) | 1.5 mL (150 u) | 2.25 mL (225 u) | 3.0 mL (300 u) | 4.5 mL (450 u) |
20 mg Vial
A 20 mg vial gives four 5 mg doses or eight 2.5 mg doses. At 10 mg/mL (2 mL of water), a 2.5 mg dose is 0.25 mL (25 units) and a 5 mg dose is 0.5 mL (50 units).
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 20 mg/mL | 0.125 mL (12.5 u) | 0.25 mL (25 u) | 0.375 mL (37.5 u) | 0.5 mL (50 u) | 0.75 mL (75 u) |
| 2 mL | 10 mg/mL | 0.25 mL (25 u) | 0.5 mL (50 u) | 0.75 mL (75 u) | 1.0 mL (100 u) | 1.5 mL (150 u) |
| 3 mL | 6.67 mg/mL | 0.375 mL (37.5 u) | 0.75 mL (75 u) | 1.125 mL (112.5 u) | 1.5 mL (150 u) | 2.25 mL (225 u) |
30 mg Vial
Some 30 mg vials are 3 mL glass — check the fill capacity before you add water, and do not add more water than the vial holds. At 10 mg/mL (3 mL of water), a 2.5 mg dose is 0.25 mL (25 units) and a 5 mg dose is 0.5 mL (50 units).
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 30 mg/mL | 0.08 mL (8.3 u) | 0.17 mL (16.7 u) | 0.25 mL (25 u) | 0.33 mL (33.3 u) | 0.5 mL (50 u) |
| 2 mL | 15 mg/mL | 0.17 mL (16.7 u) | 0.33 mL (33.3 u) | 0.5 mL (50 u) | 0.67 mL (66.7 u) | 1.0 mL (100 u) |
| 3 mL | 10 mg/mL | 0.25 mL (25 u) | 0.5 mL (50 u) | 0.75 mL (75 u) | 1.0 mL (100 u) | 1.5 mL (150 u) |
40 mg Vial
A 40 mg vial gives eight 5 mg doses or sixteen 2.5 mg doses. At the strongest mixes the draws for a 2.5 mg dose are very small — use 2 mL or 3 mL of water for a readable draw.
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 40 mg/mL | 0.0625 mL (6.3 u) | 0.125 mL (12.5 u) | 0.1875 mL (18.8 u) | 0.25 mL (25 u) | 0.375 mL (37.5 u) |
| 2 mL | 20 mg/mL | 0.125 mL (12.5 u) | 0.25 mL (25 u) | 0.375 mL (37.5 u) | 0.5 mL (50 u) | 0.75 mL (75 u) |
| 3 mL | 13.33 mg/mL | 0.1875 mL (18.8 u) | 0.375 mL (37.5 u) | 0.5625 mL (56.3 u) | 0.75 mL (75 u) | 1.125 mL (112.5 u) |
50 mg Vial
At this size, the strongest mixes give draws too small to measure accurately on a U-100 syringe — a 2.5 mg dose from a 50 mg/mL mix is only 0.05 mL (5 units). Use 2 mL or 3 mL of water.
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 50 mg/mL | 0.05 mL (5 u) | 0.1 mL (10 u) | 0.15 mL (15 u) | 0.2 mL (20 u) | 0.3 mL (30 u) |
| 2 mL | 25 mg/mL | 0.1 mL (10 u) | 0.2 mL (20 u) | 0.3 mL (30 u) | 0.4 mL (40 u) | 0.6 mL (60 u) |
| 3 mL | 16.67 mg/mL | 0.15 mL (15 u) | 0.3 mL (30 u) | 0.45 mL (45 u) | 0.6 mL (60 u) | 0.9 mL (90 u) |
60 mg Vial
A 60 mg vial is the largest strength on this page. The strongest mix is 60 mg/mL, where a 2.5 mg dose is only 0.04 mL (about 4 units) — too small to measure reliably. Use 2 mL or 3 mL of water.
| Water | Concentration | 2.5 mg | 5 mg | 7.5 mg | 10 mg | 15 mg |
|---|---|---|---|---|---|---|
| 1 mL | 60 mg/mL | 0.0417 mL (4.2 u) | 0.0833 mL (8.3 u) | 0.125 mL (12.5 u) | 0.1667 mL (16.7 u) | 0.25 mL (25 u) |
| 2 mL | 30 mg/mL | 0.0833 mL (8.3 u) | 0.1667 mL (16.7 u) | 0.25 mL (25 u) | 0.3333 mL (33.3 u) | 0.5 mL (50 u) |
| 3 mL | 20 mg/mL | 0.125 mL (12.5 u) | 0.25 mL (25 u) | 0.375 mL (37.5 u) | 0.5 mL (50 u) | 0.75 mL (75 u) |
Reconstitution
Reconstitution is simple, but the order matters. Work with clean hands and clean equipment.
- Wash your hands. Wipe both vial stoppers with an alcohol swab and let the alcohol dry before you pierce the stopper.
- Draw the BAC water volume into a syringe — draw up bacteriostatic water, not plain sterile water — and add it slowly down the inner wall of the vial of lyophilised powder. For example, 2 mL into a 10 mg vial gives 5 mg/mL; 2 mL into a 20 mg vial gives 10 mg/mL.
- Swirl gently until the powder has dissolved into a clear solution. Do not shake the vial.
- Draw the dose with a 100-unit insulin syringe (1 mL U-100). From the 5 mg/mL mix (10 mg vial in 2 mL of water), 2.5 mg is 50 units and 5 mg is 100 units.
- Choose an injection site — abdomen, outer thigh, or upper arm — pinch a skin fold, insert the needle at a 45 to 90 degree angle, inject slowly, and hold for 5 seconds before withdrawing. Use a 29 to 31 gauge needle and a new sterile syringe for every injection.
Storage
Store reconstituted tirzepatide in a refrigerator at 2–8 °C (36–46 °F). Do not freeze it: freezing can damage the peptide, and a vial that has frozen should be discarded — never try to thaw and re-use it. Keep the vial upright in its box or another dark place so it is protected from light, and keep it out of reach of children and pets.
Once mixed, use the vial within about 4 weeks. Write the mixing date and the discard date on the label so you can check at a glance — for example, a vial mixed on the 1st of the month should be finished by about the 29th.
Do not leave a mixed vial at room temperature for long periods, and do not store it in the freezer or in a car. If the solution looks cloudy or contains particles, do not use it. The approved Mounjaro and Zepbound pens have their own storage instructions in the label — for the pens, follow those. This is educational information only, not medical advice; when in doubt, ask a pharmacist.
Dosing Schedule
Tirzepatide is an FDA-approved prescription medicine, and the doses on this page are the label doses from the FDA-approved prescribing information for Mounjaro and Zepbound. The starting dose is 2.5 mg once weekly, and the dose is increased by 2.5 mg every 4 weeks as tolerated, to the maintenance dose your prescriber chooses — up to a maximum of 15 mg once weekly. Your prescriber decides the dose and when to step up; this page shows the label schedule so you can see how the maths changes as the dose increases.
The injection is once weekly, on the same day each week. If you miss a dose, follow the instructions in the label: take the missed dose as soon as you remember within 4 days, or skip it and take the next dose on the usual day. Do not take two doses within 3 days of each other. The steps increase by 2.5 mg at a time and are spaced 4 weeks apart so your body can adjust — never increase the dose faster than the label.
| Label step | Dose | When |
|---|---|---|
| Starting dose | 2.5 mg once weekly | Weeks 1–4 |
| Step 2 | 5 mg once weekly | Weeks 5–8 |
| Step 3 | 7.5 mg once weekly | Weeks 9–12 |
| Step 4 | 10 mg once weekly | Weeks 13–16 |
| Step 5 | 12.5 mg once weekly | Weeks 17–20 |
| Step 6 (maximum) | 15 mg once weekly | Week 21 onwards |
The dose is weekly, not daily. Step up only as tolerated and only on your prescriber’s instruction, and do not go above 15 mg. This is educational reference to the label, not a dosing instruction; always follow your prescriber and the label.
What You Need
To reconstitute a vial of tirzepatide you need the following:
- A vial of lyophilised tirzepatide powder.
- Bacteriostatic water (BAC water) — 0.9% benzyl alcohol in sterile water.
- A 1 mL U-100 insulin syringe (100 units).
- Alcohol swabs.
- A sharps container.
A sterile mixing syringe and needle are also useful for drawing up the BAC water. Never use tap water, and never reuse a needle or syringe — use a new sterile syringe for every draw and put used sharps straight into a sharps container. The approved Mounjaro and Zepbound pens are ready to use and are not reconstituted, so these items apply only to vial-based maths. This is educational only.
Comparing Options
Tirzepatide, semaglutide and retatrutide are all weekly injectable peptides that act on incretin receptors, but they hit different combinations of receptors.
| Peptide | Receptors | Status |
|---|---|---|
| Tirzepatide | GLP-1 + GIP (dual agonist) | FDA-approved (type 2 diabetes; weight management) |
| Semaglutide | GLP-1 only | FDA-approved (type 2 diabetes; weight management) |
| Retatrutide | GLP-1 + GIP + glucagon (triple agonist) | Investigational — not FDA-approved |
Tirzepatide is the only dual GIP/GLP-1 agonist with FDA approval for both type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Retatrutide adds a glucagon signal — the triple agonist — but it remains investigational, with no approved dose. This comparison is informational only: the three are not interchangeable, their trial results cannot be directly compared, and this page is educational reference, not medical advice.
What Is Tirzepatide?
Tirzepatide (development code LY3298176) is a dual GIP/GLP-1 receptor agonist: it activates two receptors — GIP and GLP-1 — the same two signals that help control blood sugar and appetite. It is given as a once-weekly subcutaneous injection, and it was developed by Eli Lilly.
Tirzepatide was approved by the FDA as Mounjaro for type 2 diabetes in May 2022, and as Zepbound for chronic weight management in November 2023. Zepbound was also approved for obstructive sleep apnoea in adults with obesity in December 2024. The approvals were based on the SURMOUNT and SURPASS clinical programmes.
Tirzepatide is an approved prescription medicine, supplied as a finished single-dose pen and dosed according to the label. Compounded and research vials of tirzepatide are not the approved products and are not verified by the FDA. The maths on this page is an educational reference only — always ask your prescriber or pharmacist before using tirzepatide.
Sources/References
The dose figures and product information on this page are drawn from the following sources:
- Mounjaro (tirzepatide) Prescribing Information, Eli Lilly — FDA-approved label. Starting dose 2.5 mg once weekly, increased by 2.5 mg every 4 weeks as tolerated, to a maximum of 15 mg once weekly.
- Zepbound (tirzepatide) Prescribing Information, Eli Lilly — FDA-approved label. The same titration for chronic weight management: start 2.5 mg once weekly, increase by 2.5 mg every 4 weeks, maximum 15 mg once weekly.
- FDA approval announcements for Mounjaro (May 2022, type 2 diabetes) and Zepbound (November 2023, chronic weight management), and for Zepbound in obstructive sleep apnoea in adults with obesity (December 2024).
All calculations on this page were worked from the standard formula — concentration = vial strength ÷ BAC water volume; draw volume = dose ÷ concentration; U-100 units = draw volume × 100 — and were checked against the calculator above. Educational reference only.
FAQ
How many units is 2.5 mg of tirzepatide?
For the standard mix on this page — a 10 mg vial in 2 mL of BAC water (5 mg/mL) — 2.5 mg is 0.5 mL, which is 50 units on a U-100 insulin syringe. The answer depends on your vial and water volume, so check with the calculator above.
How many units is 5 mg of tirzepatide?
From the same standard mix (10 mg in 2 mL of BAC water, 5 mg/mL), 5 mg is 1.0 mL, which is 100 units — a full 1 mL U-100 syringe. From a stronger mix — for example a 20 mg vial in 2 mL (10 mg/mL) — 5 mg is only 0.5 mL, or 50 units.
How much BAC water do I add to a 10 mg tirzepatide vial?
There is no single amount: 2 mL is the standard example on this page, and the “Reconstitution by Vial Size” tables show how different water volumes change the concentration and the draw for each vial size. Always check the fill capacity of your vial before adding water, and never add more water than a standard 3 mL vial can hold.
How much BAC water do I add to a 30 mg tirzepatide vial?
For a 30 mg vial, 3 mL of BAC water gives 10 mg/mL, so a 5 mg dose is 0.5 mL (50 units) and a 2.5 mg dose is 0.25 mL (25 units). With 2 mL the mix is 15 mg/mL, and with 1 mL it is 30 mg/mL — both are shown in the “30 mg Vial” table. Do not add more water than the vial can hold.
Which syringe do I use?
A 1 mL U-100 insulin syringe (100 units), usually 29–31 gauge. Always check the syringe label — a U-100 syringe is the standard scale used by every calculation on this page. Doses above 5 mg from the standard mix need more than 1 mL, so they need a larger syringe or a split dose.
Is tirzepatide FDA approved?
Yes. Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management, both made by Eli Lilly. Compounded or research vials are not the approved products.
How do I store tirzepatide?
Refrigerate reconstituted tirzepatide at 2–8 °C (36–46 °F), do not freeze it, use it within about 4 weeks, and protect it from light. The approved Mounjaro and Zepbound pens have their own storage instructions in the label — follow those for the pens.
Related peptide calculators
More peptide dosage calculators on this site: